Location via proxy:   
[Report a bug]   [Manage cookies]                
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention of cardiovascular complications in elderly cancer patients.
Topa E, Rizza M, Iengo M, Cuomo A, Cicia L, Di Sarro E, Miccio M, Ciaccio G, Luise MC, Formisano L, Bianco R, Carlomagno C, Picardi M, Martinelli E, Napolitano S, Troiani T, Ferrara N, Abete P, Tocchetti CG, Mercurio V. Topa E, et al. Among authors: troiani t. Vascul Pharmacol. 2024 Jun;155:107354. doi: 10.1016/j.vph.2024.107354. Vascul Pharmacol. 2024. PMID: 38985632 No abstract available.
Erlotinib in cancer treatment.
Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Bareschino MA, et al. Among authors: troiani t. Ann Oncol. 2007 Jun;18 Suppl 6:vi35-41. doi: 10.1093/annonc/mdm222. Ann Oncol. 2007. PMID: 17591829 Free article. Review.
Resistance mechanisms of tumour cells to EGFR inhibitors.
Morgillo F, Cantile F, Fasano M, Troiani T, Martinelli E, Ciardiello F. Morgillo F, et al. Among authors: troiani t. Clin Transl Oncol. 2009 May;11(5):270-5. doi: 10.1007/s12094-009-0354-6. Clin Transl Oncol. 2009. PMID: 19451059 Review.
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors.
Morgillo F, Martinelli E, Troiani T, Orditura M, De Vita F, Ciardiello F. Morgillo F, et al. Among authors: troiani t. PLoS One. 2011;6(12):e28841. doi: 10.1371/journal.pone.0028841. Epub 2011 Dec 9. PLoS One. 2011. Retraction in: PLoS One. 2024 Jan 25;19(1):e0298013. doi: 10.1371/journal.pone.0298013. PMID: 22174910 Free PMC article. Retracted.
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
Troiani T, Martinelli E, Napolitano S, Vitagliano D, Ciuffreda LP, Costantino S, Morgillo F, Capasso A, Sforza V, Nappi A, De Palma R, D'Aiuto E, Berrino L, Bianco R, Ciardiello F. Troiani T, et al. Clin Cancer Res. 2013 Dec 15;19(24):6751-65. doi: 10.1158/1078-0432.CCR-13-0423. Epub 2013 Oct 11. Clin Cancer Res. 2013. PMID: 24122793
204 results